| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8624798 | Bone | 2018 | 20 Pages |
Abstract
In patients with early and active RA, we found no difference in change in BMD between patients treated with prednisone/prednisolone versus placebo, suggesting that at least through 24â¯months, the suppression of inflammation by glucocorticoids may counterbalance their adverse effects on bone remodeling.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Anne-Birgitte Garm Blavnsfeldt, Annette de Thurah, Malissa Dawn Thomsen, Simon Tarp, Bente Langdahl, Ellen-Margrethe Hauge,